Prosecution Insights
Last updated: May 29, 2026

Examiner: SCHERBEL, TODD J

Tech Center 3700 • Art Units: 3731 3771 3773

This examiner grants 76% of resolved cases

Performance Statistics

76.2%
Allow Rate
+6.2% vs TC avg
787
Total Applications
+51.6%
Interview Lift
1139
Avg Prosecution Days
Based on 769 resolved cases, 2023–2026

Rejection Statute Breakdown

0.8%
§101 Eligibility
20.8%
§102 Novelty
55.4%
§103 Obviousness
13.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18682524 A SKIN TREATMENT DEVICE Non-Final OA KONINKLIJKE PHILIPS N.V.
18719905 TISSUE CLOSURE DEVICE Non-Final OA Cilag GmbH International
17801364 INTRAOCULAR LENS INJECTOR Non-Final OA Hoya Corporation
18595803 TELESCOPING CANNULA ARM Non-Final OA INTUITIVE SURGICAL OPERATIONS, INC.
18082254 GALLBLADDER IMPLANT Final Rejection Regents of the University of Minnesota
18827384 METHOD AND APPARATUS FOR TREATING A HIP JOINT, INCLUDING THE PROVISION AND USE OF A NOVEL SUTURE PASSER Non-Final OA Stryker Corporation
18672942 OVER THE SCOPE DEVICE AND METHOD FOR TREATING TISSUE USING A PATCH Non-Final OA BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED
18818237 INTRAGASTRIC VOLUME-OCCUPYING DEVICE AND METHOD FOR FABRICATING SAME Non-Final OA RESHAPE LIFESCIENCES INC.
17901847 TISSUE EXPANDER SLEEVE AND TREATMENT FOR SHORT BOWEL SYNDROME, VAGINAL STENOSIS, VAGINAL AGENESIS / ATRESIA, AND NEOVAGINAL DILATION Non-Final OA Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
18197692 METHOD FOR USE OF A DOUBLE-STRUCTURED TISSUE IMPLANT FOR TREATMENT OF TISSUE DEFECTS Non-Final OA Ocugen, Inc.
17855719 TISSUE FASTENING Final Rejection Children's Medical Center Corporation
17877126 SYSTEMS AND METHODS FOR SUTURING Final Rejection Ergosurgical Group Corp.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month